Bridge Biotherapeutics Stock Forecast - 8 Period Moving Average
| 288330 Stock | KRW 3,455 430.00 14.21% |
The 8 Period Moving Average forecasted value of Bridge Biotherapeutics on the next trading day is expected to be 3,345 with a mean absolute deviation of 451.34 and the sum of the absolute errors of 23,921. Bridge Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Bridge Biotherapeutics stock prices and determine the direction of Bridge Biotherapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Bridge Biotherapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Bridge |
Bridge Biotherapeutics 8 Period Moving Average Price Forecast For the 5th of December
Given 90 days horizon, the 8 Period Moving Average forecasted value of Bridge Biotherapeutics on the next trading day is expected to be 3,345 with a mean absolute deviation of 451.34, mean absolute percentage error of 276,004, and the sum of the absolute errors of 23,921.Please note that although there have been many attempts to predict Bridge Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Bridge Biotherapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Bridge Biotherapeutics Stock Forecast Pattern
| Backtest Bridge Biotherapeutics | Bridge Biotherapeutics Price Prediction | Buy or Sell Advice |
Bridge Biotherapeutics Forecasted Value
In the context of forecasting Bridge Biotherapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Bridge Biotherapeutics' downside and upside margins for the forecasting period are 3,339 and 3,351, respectively. We have considered Bridge Biotherapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 8 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Bridge Biotherapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Bridge Biotherapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.9357 |
| Bias | Arithmetic mean of the errors | 37.1934 |
| MAD | Mean absolute deviation | 451.3443 |
| MAPE | Mean absolute percentage error | 0.1096 |
| SAE | Sum of the absolute errors | 23921.25 |
Predictive Modules for Bridge Biotherapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bridge Biotherapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Bridge Biotherapeutics
For every potential investor in Bridge, whether a beginner or expert, Bridge Biotherapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Bridge Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Bridge. Basic forecasting techniques help filter out the noise by identifying Bridge Biotherapeutics' price trends.Bridge Biotherapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bridge Biotherapeutics stock to make a market-neutral strategy. Peer analysis of Bridge Biotherapeutics could also be used in its relative valuation, which is a method of valuing Bridge Biotherapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bridge Biotherapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Bridge Biotherapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Bridge Biotherapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Bridge Biotherapeutics Market Strength Events
Market strength indicators help investors to evaluate how Bridge Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bridge Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Bridge Biotherapeutics stock market strength indicators, traders can identify Bridge Biotherapeutics entry and exit signals to maximize returns.
Bridge Biotherapeutics Risk Indicators
The analysis of Bridge Biotherapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bridge Biotherapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bridge stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.1 | |||
| Semi Deviation | 5.38 | |||
| Standard Deviation | 6.42 | |||
| Variance | 41.26 | |||
| Downside Variance | 31.86 | |||
| Semi Variance | 28.9 | |||
| Expected Short fall | (5.71) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Bridge Biotherapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bridge Biotherapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bridge Biotherapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Bridge Stock
The ability to find closely correlated positions to Bridge Biotherapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bridge Biotherapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bridge Biotherapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bridge Biotherapeutics to buy it.
The correlation of Bridge Biotherapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bridge Biotherapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bridge Biotherapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bridge Biotherapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Bridge Stock
Bridge Biotherapeutics financial ratios help investors to determine whether Bridge Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bridge with respect to the benefits of owning Bridge Biotherapeutics security.